To AI or not to AI in Neurology: That is the Question
2025-12-12 13:30 - 14:30 (Europe/Vienna)
This webinar will explore state-of-the-art AI approaches for advancing neuroimaging, with a particular focus on quantitative PET. It will cover the entire imaging pipeline, from preprocessing, acquisition, and tomographic reconstruction to quantification, segmentation, denoising, and resolution enhancement, demonstrating how modern AI can enable more reproducible and robust brain PET biomarkers. Through two expert presentations and practical case examples, the webinar will showcase how AI-driven methodologies are reshaping neuroimaging research and supporting more accurate diagnosis and disease monitoring.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

Learn the principles behind AI-based quantitative PET methods

Understand how AI can enhance each stage of the neuroimaging pipeline, from preprocessing and reconstruction to segmentation, denoising, and resolution recovery.

Critically assess when AI meaningfully improves neuroimaging workflows

Recognize emerging opportunities and challenges in integrating AI tools into brain PET

Target Audience

Nuclear physicians, medical physicists, imaging scientists and radiologists working in PET neuroimaging

Faculty

Pablo Aguilar FernándezModerator

Dimitris VisvikisSpeaker

Charalampos TsoumpasSpeaker

Event Overview

Fundamentals of Research in Imaging and Theranostics – Part 1: Research Design
2026-12-31 00:00 - 23:59 | Online
UEMS EACCME has granted the accreditation of 4 CME credits for this event.

This online course is part of a long line of research methodology which is aimed at providing interested participants with information about the preclinical development and clinical translation, as well as the design, conductance and reporting of clinical research trials, with a specific emphasis on radiopharmaceuticals for both diagnostic and therapeutic applications.

These first two modules will represent part one of the course.

Module 1 will focus on the entire path from preclinical development to clinical translation of an imaging compound, including the preclinical studies needed for the selection of a new candidate for clinical translation, an overview of EU legislation on radiopharmaceuticals for diagnosis and therapy, and the assessment of quality data and non-clinical data (pharmacology, dosimetry and toxicology) for the IMP dossier.

Module 2 will be focused on the design of a proper trial. It will cover: the definition of objectives, aims, endpoints, population, statistical methods and examples of trial design schemes, as well as dosimetry as far as healthy organs and in case of therapy tumour-absorbed dose. It will have a special focus on phase 0, phase 1-2 trial, early clinical phase 0-1-2 and investigator-driven clinical trial.

Save yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives:

Learn about:

Preclinical development and clinical translation of radiopharmaceuticals

The legislation on radiopharmaceuticals with a specific focus on the European scenario

Requirements of IMPD for radiopharmaceuticals for imaging agents and theranostic/therapeutic molecules Interpretation of preclinical data to properly design and plan the clinical trial

Phase 0, phase 1 and phase 2 clinical trials with radiopharmaceuticals design

Phase 0, phase 1 and phase 2 clinical trials with radiopharmaceuticals conductance

GMP, GLP and GCP principles

Importance of radioprotection and dosimetric estimates in early phase clinical trials

Target Audience:

Researchers, scientists, nurses, pharmacologists, radiopharmacists, residents and specialists in Nuclear Medicine/Oncology/Radiology who want to understand how clinical trials with radiopharmaceuticals in the early phase are unique and how the corresponding documents and trial design should be appropriately planned.

ProgrammeClick to see the full event programme. View the Programme

Faculty

Paola Anna ErbaUniversità degli Studi di Milano-Bicocca, Italy

Sona BalogovaComenius University, Bratislava, Slovakia

Elisabeth von GuggenbergMedical University Innsbruck, Austria

Martina SolliniVita-Salute San Raffaele University, Milan, Italy

Luigi AlojUniversity of Cambridge, United Kingdom

Meltem OcakIstanbul University, Turkey

Peter LavermanRadboud Universiteit Nijmegen, The Netherlands

Jane SosabowskiQueen Mary, University of London, United Kingdom

Petra KolencUniversity Medical Centre Ljubljana, Slovenia

Clemens DecristoforoMedical University Innsbruck, Austria

Piotr GarnuszekPOLATOM, Warsaw, Poland

Renata MikolajczakPOLATOM, Warsaw, Poland

Theodosia MainaNCSR Demokritos, Athens, Greece

Mark KonijnenbergErasmus MC, Rotterdam, The Netherlands

Registration Details

Registration Fee

Course Fee Free

Event Overview
